Access to Medicine Archives

Return to Access to Medicine Homepage

Archived Media, by date:

April 24, 2019 – Civil society letter to House Democratic Leadership outlining red lines for meeting the Better Deal promise on Medicare drug price negotiation

April 9, 2019 – Public Citizen Statement for the Record of House Ways & Means Committee Markup of the Prescription Drug STAR Act (H.R. 2113)

February 7, 2019 – Comments of Public Citizen for the 2019 Special 301 Review

January 17, 2019 – Overwhelming Majority of Americans Support Medicare Negotiation: Public Citizen Analysis Finds Misleading Claims About Patient Support in Letter Opposing Efforts to Reduce Prescription Drug Prices

December 4, 2018 – Analysis: NAFTA 2.0: U.S.-Mexico-Canada Agreement Chapter 20, Pharmaceutical Related Patent Provisions (en español here)

October 10, 2018No More Secrets: Congress Bans Pharmacist ‘Gag Orders’ On Drug Prices

October 10, 2018Trump’s So-Called Medicine ‘Gag Clause’ Ban Barely Scratches the Surface for Consumers in Need of Relief

October 9, 2018A Nobel Prize-Winning Cancer Therapy Will Be Unaffordable for Most Americans. Public Pharmaceuticals Can Help Change That

October 5, 2018NOTE TO REPORTERS: Doggett’s Medicare Negotiation Plan Frightens Big Pharma, Now Has More Than 100 Co-Sponsors

October 1, 2018 Potentially Lethal: New NAFTA IP chapter requires 10-year biologics monopolies (worst such rule in a U.S. FTA)

October 1, 2018 Common Dreams: The Good, the Bad, and the Ugly on NAFTA 2.0

September 5, 2018Sen. Smith’s Legislation Would Make Medicines Affordable

September 5, 2018 UCLA’s Patent War in India Prevents Access to Prostate Cancer Treatment Worldwide

September 4, 2018Big Pharma, Corporations Dealt a Good Hand With McCain’s Replacement

August 29, 2018 Trade deal between U.S. and Mexico is criticized for allowing high drug prices to continue

August 7, 2018Azar’s Prescription Cost Plan Needs Closer Scrutiny

August 2, 2018 This Bill Would Help Us Afford Prescription Drugs

July 27, 2018Vermont Representative Among Sponsors Of Prescription Drug Pricing Bill

July 25, 2018[STAT +] Democrats introduce a bill to allow Medicare negotiations and sidestep patents if talks fail

July 24, 2018 Legislation Would Provide Leverage Through a Competitive License to Allow Competition If Negotiations Fail

July 24, 2018[Inside Health Policy] Public Citizen Touts Doggett’s Souped-Up Part D Drug Negotiation Bill

July 17, 2018 Activists Are Urging the FDA to Break the Patent on Truvada. Here’s Why

July 17, 2018 Consumer Groups Letter on Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs

July 17, 2018Industry responds to Trump’s drug plan with more finger-pointing

July 17, 2018Public Citizen Comments Regarding HHS Blueprint to Lower Drug Prices and Reduce Out of Pocket Costs

July 12, 2018Pfizer doesn’t deserve any credit for ‘rolling back’ its price increases at Trump’s demand. Here’s why

July 5, 2018Local Health Departments Pay High Price For Opioid Overdose Drug [Behind Paywall]

June 26, 2018 – Press Release: Activists, Organizers and Advocates Gather to Fight Big Pharma 

May 30, 2018 – Editorial: Trump’s drug plan is not a prescription for savings

May 25, 2018Profiteering from the opioid crisis

May 21, 2018 Can an Obscure, 100-Year-Old Patent Law Take On Big Pharma?

May 11, 2018Trump plan for drug prices seen largely sparing industry

May 11, 2018 – Opinion: Narcan saved me from an opioid overdose. President Trump should make this drug cheaper.

May 10, 2018White House Set to Announce Plan to Curb Drug Prices

May 7, 2018 Trump made high drug prices his issue. Democrats think they can take it back.

May 4, 2018 Trump to deliver major address on drug prices, but advocates predict small steps

May 3, 2018Fact Sheet: About Government Use of Patented Inventions

May 3, 2018Fact Sheet: About the Public Citizen, Baltimore City Health Department Naloxone Request

May 3, 2018Letter: Public Citizen, Baltimore City Health Department Request Trump Administration Exercise Government Use Authority on Naloxone Treatments

May 3, 2018 Gov’t urged to invoke authority to boost OD antidote access

May 2, 2018Brook Baker: Lies, Distortions, and False Promises: The U.S. Position on Compulsory Licenses in the 2018 Special 301 Report

April 27, 2018 – Press Release: Trump to the World: Raise your Medicine Prices — Or Else

April 25, 2018 US Waits for Trump to Tackle Drug Pricing as Big Pharma Goes on Lobbying Blitz

April 23, 2018 Note to Reporters: Trump Needs to Rethink Prescription Prices in Light of Canceled Speech 

April 10, 2018 – Drug companies paid $116 million to patient advocacy groups in 2015 alone, new data suggests

March 15, 2018 – The Sick Paying for the Healthy: How Insurance Companies Drive Up Drug Prices

March 15, 2018Public Citizen Statement for Special 301 Hearing March 2018

March 15, 2018 Public Citizen letter to Congress regarding omnibus spending package and the Medicare Part D donut hole

February 23, 2018Trump wants lower drug prices. Menendez’s Republican challenger fought to keep them high.

February 19, 2018Public Citizen Analysis: The Good, the Bad and the Ugly of the Trump Administration’s Drug Pricing Measures from its FY 2019 Budget Proposal

February 17, 2018Trump wants lower drug prices. Menendez’s Republican challenger fought to keep them high

February 12, 2018McCain and Baldwin to Trump: Hold pharma’s feet to the fire on drug prices

February 9, 2018 Comments of Public Citizen for the 2018 Special 301 Review

February 8, 2018Senate Republicans Kept Provision to Fight High Drug Prices Out of Spending Bill, Democrats Say

January 29, 2018 Peter Maybarduk on Busting up Big Pharma’s Monopoly Power

January 15, 2018 Public Citizen Comment on the draft guidance and recommendations put forth by the Connecticut Health Cost Commission (the Commission) on the topic of controlling prescription drug prices

January 12, 2018 Other98: Our Would-Be Health Secretary Said Some Pretty Sick Stuff in His Confirmation Hearing

January 12, 2018LA Times: Trump’s pick for health secretary makes clear he’s totally the wrong guy for the job

January 11, 2018 – Public Citizen Comments to the FDA Supporting Draft Guidance Restricting Orphan Drug Designations for Pediatric Uses

January 10, 2018Common Dreams: ‘No One Should Be Fooled’: Warren Rips Trump’s HHS Pick Over Desire to Gut Medicaid

January 9, 2018Senate Finance Committee evaluates Alex Azar to be the next HHS secretary

January 3, 2018Civil Society Letter Urging Senators to Reject the Nomination of Alex Azar for HHS Secretary

December 21, 2017Letter to Spark Therapeutics About Luxturna Research and Development

December 5, 2017 Managed Care Mag: Drug Prices – Why so high and why so #&*! complicated

November 28, 2017The Hill: Fight erupts over tax credit for ‘orphan’ disease drugs

November 15, 2017With Trump’s HHS pick Big Pharma takes over our health system – by Justin Mendoza, Organizer, Access to Medicines Program

November 13, 2017Common Dreams: ‘Why Not Freddy Krueger?’ Trump Picks Big Pharma Exec Alex Azar to Head HHS

November 4, 2017Ohio’s Opportunity to Take Control of Medicine Prices

November 3, 2017Civil Society Letter to Senate re: CHIP/Health Care Offsets

November 1, 2017 Consumer Affairs: State governments take on drug companies to curb rising prices

October 19, 2017Civil Society Letter to Senate Judiciary Committee re: Allergan Mohawk Scheme

October 5, 2017Morning Consult: Grassley Pressing to Include Drug Pricing Measures in CHIP Reauthorization

October 2, 2017Fierce Pharma: AbbVie promises it’s sticking with CEO’s price-hike pledge, at least through 2018

September 26, 2017 Did someone say pledge? AbbVie may reverse its promise on price hikes – by Ed Silver

September 25, 2017 – Nevada’s drug-pricing law faces new court hearing next month

September 25, 2017Public Citizen Finance Hearing Statement on Graham Cassidy

September 20, 2017Public Citizen Written Comments on FDA Public Meeting: “Administering the Hatch-Waxman Amendments: Ensuring a Balance Between Innovation and Access”

September 18, 2017  – California Drug Price Bill Sweeping In Scope, Lacking In Muscle

September 18, 2017 Citizen Lobbying Kit on Drug Prices

July 24, 2017Trump’s Plan to Make Drugs Cheaper Could End Up Making Them More Expensive

July 19, 2017Public Citizen Testimony at FDA Hearing: “Administering the Hatch-Waxman Amendments: Ensuring a Balance Between Innovation and Access”

July 11, 2017 Drug cost proposals lack Trump’s campaign pledges, consumer watchdog says

July 6, 2017Brief: Will Trump Adopt Pharma’s Proposals on Value-Based Pricing?

July 6, 2017 Brief: Generic Exclusivity Expansion is Unlikely to Lower Prescription Drug Prices

July 6, 2017Brief: Generic Priority Review Vouchers are Not the Answer to Price Gouging

July 6, 2017Leaked Discussion Documents on the Trump Adminstration’s Drug Prices Agenda

June 30, 2017 – Civil Society Letter to Senator Ron Wyden regarding India’s intellectual property rights policies.

June 30, 2017 – First Post: US pressure on India to grant more patents on pharma products ‘appalling’, say health advocates

June 26, 2017 – Statement: Trump and Modi Discussions: A Matter of Life and Death

June 26, 2017 – Trump’s Plan for Drug Pricing Executive Order Is a Big Pharma Wish List

June 23, 2017Statement: Draft Trump Executive Order Abandons Promises to Challenge Big Pharma and Make Medications Affordable

June 20, 2017What Trump Should Do to Lower Medicine Prices

June 20, 2017Exporting Monopoly Rules Does Not Lower U.S. Prescription Drug Prices

June 20, 2017 – Statement: Draft Trump Order Abandons Campaign Promises to Challenge Big Pharma and Make Medications Affordable

June 16, 2017 – Report: Key Questions on Patent Disclosure Requirements for Genetic Resources and Traditional Knowledge by Burcu Kilic for the World Intellectual Property Organization.

June 16, 2017Note to Reporters: Trump Administration Meets on Pharmaceutical Proposals, We Can Tell You How They Will Affect Patients

June 15, 2017 – Press Release: Brown-Gillibrand Bill Would Stop Pharma Price Gouging

June 7, 2017Comments from Public Citizen and civil society group re: Louisiana hepatitis C drug pricing

June 7, 2017Statement: House Energy and Commerce Members Challenge Administration to Increase Access to Medicines

May 18, 2017 Are we finally ready to do something about Big Pharma’s price-gouging? by Steve Knievel and Dr. Azza AbuDagga of Public Citizen

May 17, 2017 – New Haven Register:  Support bill for lower drug prices: Letter to the editor by Justin Mendoza:

May 11, 2017 The Pharma Letter: A move to help patients or create exclusive cartel? Mixed views on PhRMA’s big change

May 10, 2017 Letter: Pass the Creating and Restoring Equal Access to Equivalent Samples Act of 2017

May 10, 2017 Data exclusivity in the Regional Comprehensive Economic Partnership (RCEP)

May 10, 2017Report: Data exclusivity in the Regional Comprehensive Economic Partnership (RCEP)

May 9, 2017Statement: Big Pharma to Become Even More Exclusive, More Expensive Cartel In False Attempt to Gain Friends

May 4, 2017Statement:Trumpcare Would Repeal Prescription Coverage and Provide Tax Breaks for Big Pharma

April 27, 2017 Letter: Pass the Creating and Restoring Equal Access to Equivalent Samples Act of 2017 (CREATES Act)

April 20, 2017 – New York Times: How to Stop Drug Price Gouging   

April 11, 2017 – Public Eye: Compulsory Licensing in Colombia: Leaked Documents Show Aggressive Lobbying by Novartis

April 11, 2017Press Release: Just Three of World’s Top 28 Pharmaceutical Corporations Agree to Limit Price Hikes to Single Digits

April 11, 2017Report: Large Majority of Prescription Drug Corporation CEOs Will Not Commit to Limiting Price Increases * AbbVie, Inc. pledged at the time of this report’s publication that it would limit price increases to single digits. On September 25, 2017 Fierce Pharma reported that executives have gone back on this pledge, saying the company “has the flexibility to revert to more than one price increase per year and to double-digit increases in 2018 and beyond.”

April 10, 2017The Intercept: Big Pharma Funds “Independent” Advocacy Groups Attacking Drug-Price Reduction Bill

April 7, 2017Truthout: Could Legalizing Prescription Drug Imports Break Big Pharma?

April 4, 2017Statement: Public Citizen Applauds Rep. Doggett and 50 Members of Congress Who Called on Trump to Use His Authority to Lower Medication Prices

April 3, 2017CNN: When $65,000 a year for a drug is applauded

March 31, 2017Press Release: Pharmaceutical Industry Profits Exceed R&D Costs in 2013, 2014 and 2015

March 31, 2017Report: Pharmaceutical Industry Profits Exceed Industry’s Self-Reported R&D Costs

March 30, 2017Letter from civil socitey to congressional leadership in opposition to proposed cuts to the NIH and Fogarty International Center in the White House budget

March 29, 2017Senators and members of Congress introduce far-reaching legislation to Improve Access to Affordable Prescription Drugs

March 29, 2017Press Release: Landmark Legislation Would Lower U.S. Prescription Prices

March 28, 2017New York Times: Severe Eczema Drug is Approved by F.D.A.; Price Tag is $37,000 a Year

March 15, 2017STAT: Cancer Patients Skipping Medicines or Delaying Treatment Due to High Drug Prices

March 6, 2017Peter Maybarduk Testimony in Support of SB 442, Connecticut Drug Pricing Transparency Bill

March 1, 2017Nature: Hepatitis C Drugs Re-energize Global Fight over Patents

February 21, 2017Cox Washington Bureau: Senators Demand Answers Over Skyrocketing Prices for Overdose Drug

February 19, 2017CTV News: Outrageous price, approval a concern for drug to treat deadliest genetic disease afflicting children

February 17, 2017STAT: Pharma trade group urges US trade rep to take action against Colombia

February 10, 2017Statement: In Strict Party-Line Vote, Senate Republicans Confirm Tom Price as Secretary of Health and Human Services

February 9, 2017Public Citizen Comments for USTR’s 2017 Special 301 Review

February 6, 2017Truthout: Big Pharma Launches Sentimental Ad Campaign to Distract From Skyrocketing Drug Prices

February 4, 2017NPR: Drugmaker Kaleo Raises Price of Life-Saving Drug by Thousands

February 3, 2017 RNZ: US President Signals Paying More for Medicines FTA Bottom Line

January 31, 2017Washington Post: Democrats Block Confirmation Votes for Sessions, Price and Mnuchin

January 31, 2017Washington Post: Trump Calls for Lower Drug Prices, Fewer Regulations in Meeting with Pharmaceutical Executives

January 31, 2017New York Times: Trump Vows to Ease Rules for Drug Makers, but Again Zeros In on Prices

January 31, 2017Bloomberg: Mylan Faces U.S. Antitrust Investigation on EpiPen

January 30, 2017The Huffington Post: Trump, Democrats and the Left Killed Obama’s Big Trade Deal. Here’s How it Happened?

January 27, 2017Devex: Zika vaccine could be delayed, unaffordable after US Army grants exclusive rights to pharma company

January 24, 2017Public Citizen: Impression Products, Inc. v Lexmark International, Inc

January 17, 2017Media Alert: U.S. Rep. Tom Price Should Not Be Confirmed As HHS Secretary

December 13, 2016Statement by Steve Knievel: HHS Report Suggests That Patient Health Continues to Take a Back Seat to Medical Companies’ Pursuit of Maximum Profits

December 12, 2016IP Watch: UAEM Targets Accessible Medicines, R&D Financing, Publicly Funded Research

December 12, 2016The Hill: Gilead CEO’s Apology for Drug Prices are Useless When No Action is Taken

December 11, 2016New York Times: Lives and Profits in the Balance: The High Stakes of Medical Patents

December 9, 2016New York Times: Wary Drug Makers Move to Fend Off Further Attacks Under Donald Trump

December 6, 2016IP Watch: TPP May be Dead – But Its Impact Lingers

December 5, 2016Harvard Law’s Bill of Health: What is the Right Number of Unsafe, Ineffective Drugs for the FDA to Approve?

December 5, 2016Los Angeles Times: The 21st Century Cures Act: A Huge Handout to the Industry Disguised as a Pro-Research Bounty

December 1, 2016STAT: 21st Century Cures Act Would Distort the Meaning of FDA Approved

December 1, 2016Business Standard: Would Washington’s FDA Fix Cure the Patients or the Drug Industry?

December 1, 2016The Atlantic: Congress Nears a Breakthrough on Medical Research Funding

December 1, 2016Drug Money: FDA Depends on Industry Funding; Money COmes with “Strings Attached”

December 1, 2016Drug Money: In FDA Meetings, “Voice” of the Patient often Funded by Drug Companies

November 30, 2016Statement: 21st Century Cures: Bad Deal for Patients. Senate Should Reject

November 30, 2016Los Angeles Times: House Approves Sprawling Bill that Would Expand Medical

November 30, 2016Health Affairs Blog: The 21st Century Cures Act is Still a Bad Deal for Patients

November 30, 2016Washington Post: Bill Expediting New Medical Treatments Passes House

November 30, 2016Star Tribune: U.S. House Passes 21st Century Cures Act

November 30, 2016STAT: House Approves Landmark 21st Century Cures Act, Sending Landmark Bill to the Senate

November 28, 2016Statement: Sanders Statement on the 21st Century Cures Act

November 28, 2016STAT: Elizabeth Warren rips 21st Century Cures bill and vows to fight it

November 28, 2016Updated Fact Sheet: Preventing Patient Harm in 21st Century Cures (Nov. 28 version)

November 28, 2016Wall Street Journal: Drugmakers Find Competition Doesn’t Keep a Lid on Prices

November 26, 2016Wall Street Journal: Lawmakers Try for Year-End Bill on Medical Research, Devices and Opioid Addiction

November 25, 2016NPR: Legislation That Would Shape FDA And NIH Triggers Lobbying Frenzy

November 21, 2016Fact Sheet: Preventing Patient Harm in 21st Century Cures and Beyond (Nov. 21 version)

November 21, 2016The Hill: Lawmakers must ask tough questions about the 21st Century Cures Act

November 18, 2016Washington Post: Letter: Big Pharma-backed bill won’t cure the FDA

November 18, 2016Yes! Magazine: How a Battle Over Affordable Medicine Helped Kill the TPP

November 17, 2016Statement: Fraud Charges Are Welcome in Valeant, Philidor Kickback Scheme

November 15, 2016Statement: TPP RIP

November 14, 2016USA Today: Some Medicare, Medicaid drug prices soar as reform uncertain

November 13, 2016La Republica: Peter Maybarduk: “El nivel de protección monopólico para medicinas subirá con el TPP”

November 11, 2016Medium: No, Trump Didn’t Kill the TPP — Progressives Did

November 7, 2016America – The National Catholic Review: Remedies Beyond Reach

November 3, 2016Public Citizen, Consumers Union and others send letter calling on Congress not to advance the so-called 21st Century Cures package during the lame duck sessions

November 1, 2016Washington Monthly: Just the Medicine — How the next president can lower drug prices with the stroke of a pen.

October 28, 2016New York Times: The U.S. Is Standing in the Way of Cheaper Drugs for the Poor

October 28, 2016Foreign Affairs: The TPP and Drug Prices — Not a Settled Matter

October 27, 2016Neritam: A Mother’s Plea to CEO After EpiPen Price Jumped 400%

October 27, 2016Morning Consult: House Democrats Still Working Toward Agreement on Cures

October 27, 2016Politico: Why Liberal Groups Want ‘Cures’ Legislation Put on Ice

October 27, 2016World Health Organization: Over 1 million treated with highly effective hepatitis C medicines

October 26, 2016Inside Health Policy: Labor Unions, Advocates: Don’t Move on Cures Without Drug Pricing Reforms

October 26, 2016The Hill: Liberal Groups Call for Delaying Cures Bill to Next Year

October 26, 2016Letter from AARP, AFL-CIO, Consumers Union, Doctors Without Borders & Oxfam America calling on President Obama not to include damaging biologics language in implementing legislation for TPP or in related side letters

October 25, 2016International Journal of Health Services: The Trans Pacific Partnership Agreement and Pharmaceutical Regulation in Canada and Australia

October 24, 2016Elliott: I’m Being Charged More for my Prescription Drugs. What’s Going on Here?

October 18, 2016Fair Warning: Swarms of Drug Industry Lobbyists and Campaign Cash Stymie Bid to Restrain Medicare Prescription Costs

October 17, 2016STAT: HHS is urged to allow a drug maker to export cheap versions of pricey cancer med

October 12, 2016Press Release: Rep. Pocan Urges President Obama to Take Executive Action to Lower Prescription Drug Prices

October 11, 2016The Wire: US’s Inconsistent Policies on Pharma Could Compromise Global Access to Medication

October 10, 2016Politico: Groups Take Aim at Pharma in TTIP

October 3, 2016Common Dreams: In Boon for Big Pharma, TTIP Would Lock In High Drug Prices: Report

October 3, 2016Policy Report from Public Citizen, Health Action International and Commons Network: TTIP and Affordable Medicines – How TTIP May Obstruct Progress Towards Sustainable Access To Medicines

September 22, 2016Al Jazeera English: Mylan CEO faces tough questioning in Congressional EpiPen hearing (video)

September 21, 2016 Fact Sheet: Reality Checking Mylan CEO’s Testimony on EpiPen Prices

September 20, 2016Press Release: American EpiPen Price as Much as Nine Times Higher than in Other Wealthy Countries, Public Citizen Survey Shows

September 11, 2016Chicago Sun Times: Editorial: Get to bottom of drug company overpricing

September 3, 2016The Independent Record: Insulin price scandal hurts many more than EpiPen issues

September 1, 2016Washington Post: Mylan, corporate tax deserter, is taking those EpiPen profits and fleeing the country

August 31, 2016STAT: How Mylan tried to keep Teva from selling a generic EpiPen

August 31, 2016Storify: Outrage Against EpiPen Price-Gouging & Action Demanding Mylan Reverse the Price Hikes

August 30, 2016WTAE Pittsburgh: Protesters demand change at headquarters of Mylan Pharmaceuticals

August 30, 2016Pittsburgh Post-Gazette: EpiPen furor brings protestors to Mylan headquarters in Cecil

August 30, 2016NPR: Activists Deliver Petitions To EpiPen Maker’s Canonsburg Headquarters

August 30, 2016Public Citizen’s Photos from the EpiPen Petition Delivery

August 30, 2016Statement: Mylan Must Lower EpiPen Price

August 30, 2016Press Release: Public Interest Groups to Mylan: Reverse the EpiPen Price Hikes Immediately

August 30, 2016Democracy Now!: Why Are We Paying $300 for an EpiPen That Holds Only $1 Worth of Medicine?

August 29, 2016Washington Post: House Oversight Committee investigating drugmaker Mylan over EpiPen price hike

August 29, 2016Washington Post: Mylan to introduce a half-price generic version of EpiPen

August 29, 2016New York Times: Mylan Tries Again to Quell Pricing Outrage by Offering Generic EpiPen

August 29, 2016NBC Nightly News: Full Broadcast — segment on EpiPen Price Hikes with Peter Maybarduk begins at minute 9:20

August 29, 2016Huffington Post: EpiPen Maker’s Latest Offer: Still Not Good Enough (authored by Public Citizen President Robert Weissman)

August 29, 2016Media Advisory: Groups to Mylan: EpiPen Discounts for Some Consumers Not Enough, True Price Reduction and Federal Reforms Needed

August 25, 2016Statement: Mylan’s Announcement on EpiPen Prices: Too Little Too Late

August 24, 2016Petition: Stop Immoral Price Gouging for Life-Saving EpiPen

August 23, 2016Kaiser Health News: Government-Protected ‘Monopolies’ Drive Drug Prices Higher, Study Says

August 22, 2016New York Times: EpiPen Price Rise Sparks Concern for Allergy Sufferers

August 16, 2016USA Today: For drug price reform, patients need to connect: Your Say

August 10, 2016California Healthline: Can Drug Price Transparency Keep Costs Down?

August 4, 2016Washington Post: High prices make once-neglected ‘orphan’ drugs a booming business

August 4, 2016STAT News: Pharma dollars back patient groups that oppose Medicare Part B overhaul

August 4, 2016 – Report: Patients’ Groups and Big Pharma — Three in Four Patients’ Groups That Sided With the Pharmaceutical Industry Against Medicare Drug Price Reforms Received Industry Money

August 4, 2016Press Release: Majority of Patients’ Groups Siding With Big Pharma Against Medicare Part B Pricing Reforms Receive Industry Funding

August 4, 2016CitizenVox: Pharma Funding Among Patients’ Groups

July 25, 2016AP: What Are the Top 20 Priciest Medicare Prescription Drugs?

July 25, 2016STAT: State Department accused of interfering with efforts for affordable medicines

July 22, 2016Huffington Post: Right To Health, Colombia And US Congress (authored by Todd Howland, Representative of the UN High Commissioner for Human Rights in Colombia)

July 21, 2016CitizenVox: An Important Remedy for Pharma’s Exorbitant Pricing

July 21, 2016Forbes: How Abbvie’s Humira Undercuts The Drug Industry Price Defense

July 20, 2016Letter from 56 Non-profit Organizations and Academic Experts to Secretary Kerry Regarding State Department Pressure Against Access to Medicines Efforts

July 20, 2016Public Health, Human Rights and Faith Organizations Question State Department Pressure Against Global Access to Medicines Initiatives

July 16, 2016New York Times: Makers of Humira and Enbrel Using New Drug Patents to Delay Generic Versions

July 15, 2016Huffington Post: Taxpayers Funded A Lifesaving Drug And Guess What Happened Next (authored by Sen. Bernie Sanders)

July 14, 2016Public Citizen joins generics industry representatives and others in letter supporting the CREATES Act

July 13, 2016CitizenVox: Pharma (contribution) Addicts in Congress

July 12, 2016Public Citizen joins consumer groups in letter supporting the CREATES Act

July 11, 2016Report: Pharma’s Orders — U.S. Representatives Who Sided With Big Pharma in Medicare Lobbying Fight Received 82% More Industry Campaign Contributions

July 11, 2016Action: Tell Congress — Serve the People, NOT Big Pharma

July 11, 2016Press Release: Pharmaceutical Industry Funding Influences Lawmakers in Contentious Medicare Part B Reform Battle

July 8, 2016Public Citizen letter in U.S. News and World Report: An Overdue Fix for Medicare

July 1, 2016Letter from Public Citizen to U.S. Congress Conference Committee for the Comprehensive Addiction and Recovery Act

June 28, 2016Media Advisory: Press Call to Explore NIH Patent Policies Compromising Medicine Affordability, the Agency’s Transparency, More

June 27, 2016Public Citizen Joins Coalition in Letter Supporting and Calling for Improvements to CMS’ Medicare Part B Prescription Drug Pricing Demonstration

June 24, 2016Press Release: Bipartisan Legislation Could Help Reduce Prices of Lifesaving Medications

June 24, 2016Colombian civil society statement on Resolution 2475

June 23, 2016Press Release: Schakowsky, Brown, McCain Introduce Bipartisan Legislation to Lower Costs of Life-Saving Drugs

June 23, 2016Press Release: Brown, McCain, Schakowsky Introduce Bipartisan Legislation to Lower Costs of Life-Saving Drugs

June 21, 2016Slate: The U.S. Chamber of Commerce’s IP Myth

June 16, 2016Medium: The High Health Costs of TPP’s “Free Trade” (authored by Joseph Stiglitz)

June 20, 2016Statement: Colombia Ministry of Health Ignores Corporate Threats and Possible U.S. Interference, Improves Affordable Access to Cancer Treatment

June 20, 2016Statement: NIH Turns Its Back on Patients; Decision to Refuse Generic Competition With Xtandi Harms Public Health

June 20, 2016NIH Director Francis Collins Final Response to Xtandi March-in Petition

June 17, 2016Reaction of AFIDRO, association of patent-based pharmaceutical companies, to Colombian Ministry of Health public interest declaration on imatinib

June 17, 2016Colombia Ministry of Health Resolution 2475 of 2016, declaring imatinib in the public interest

June 16, 2016La Silla: Alejandro Gaviria supera un obstáculo pero no tiene ganada la carrera

June 10, 2016The Nation: The Trans-Pacific Partnership Will Hurt Farmers and Make Seed Companies Richer

June 10, 2016KEI: Novartis complaints over public interest declaration debunked

June 9, 2016STAT News: Colombia plans to unilaterally lower the cost of a Novartis cancer drug

June 9, 2016Audio from Minister Gaviria’s press conference on imatinib, in Spanish

June 9, 2016AP: Colombia to force Novartis to lower prices of cancer drug

June 9, 2016Reuters: Colombia to set new price for Novartis cancer drug: minister

May 29, 2016El tiempo: Cara y sello del debate por el fármaco contra la leucemia

May 27, 2016Letter from Colombian Ministry to Civil Society Clarifying that Compulsory Licenses Do Not Constitute Expropriation under Colombian Law

May 27, 2016Campaign for America’s Future: Sanders, Brown Speak Out On Gunboat Diplomacy For Corporations

May 27, 2016Press Release: Groups Demand Answers from Obama Administration Regarding Alleged U.S. Interference in Colombian Health Measure (see the letter here)

May 26, 2016STAT: Bernie Sanders accuses US Trade Rep of intimidating Colombia over Novartis patent

May 25, 2016 Letter from WHO to Colombia Clarifying Right to Issue Compulsory Licenses

May 25, 2016Rep. Levin Press Release: House Democrats Press USTR to Clarify Position on Compulsory Licensing for Generic Medicines in Colombia (see the letter here)

May 25, 2016Knowledege Ecology International: WHA 69: Colombian Minister of Health Calls on WHO to Support Sustainable Model for Health, Regulation of Monopolies

May 23, 2016Pronunciamiento de la Conferencia Episcopal sobre el proceso de declaratoria de existencia de razones interés público con efectos de licencia obligatoria para el Imatinib

May 21, 2016Salt Lake City Tribune: Op-ed: Hatch puts Colombian peace at risk to help Novartis

May 20, 2016Wall Street Journal: Colombia Threatens to Override Novartis’s Patent on Gleevec

May 19, 2016Letter: Public Citizen Joins Knowledge Ecology International, Oxfam America and Health GAP in Writing to Senator Hatch Regarding Reported Pressure On Colombia Not to License Cancer Medicine Glivic

May 18, 2016Washington Post: Dispute with Swiss drugmaker has Colombian officials worried about U.S. peace funding

May 18, 2016Press Release: Groups Warn Against Senate HELP Committee Members’ Legislative Sleight of Hand on Cures Act

May 18, 2016STAT: Colombia to Novartis: Lower the price of your cancer drug, or else

May 18, 2016Reuters: Deal still possible in Colombia-Novartis cancer drug talks : minister

May 17, 2016El Espectador: Bernie Sanders acusa a Oficina de Comercio de EE.UU. de presionar a Colombia en caso imatinib

May 17, 2016Letter from more than 120 Academics and Advocates to President Santos of Colombia Affirming Colombia’s Right to Issue a Compulsory License on Cancer Medicine Imatinib (marketed by Novartis under the brand name Glivec)

May 16, 2016El Espectador: Expertos apoyan decisión de Minsalud de reducir precio del Imatinib, medicamento para el cáncer

May 12, 2016Washington Post: A simple way for the government to curb inflated drug prices

May 12, 2016STAT: Colombian health minister is warned not to sidestep Novartis patent

May 11, 2016Huffington Post: Colombia Fears U.S. May Reject Peace Plan To Protect Pharma Profits

May 10, 2016Counter Punch: From Cancer Patient to Medicines Activist

May 10, 2016The Caravan: What Happened to the Indian Official that Rejected the US Drug Company Gilead’s Patent Application in 2015

May 10, 2016El Espectador: Las presiones de EE.UU. para que Colombia no regule el precio del imatinib

April 28, 2016Swiss Broadcasting Corporation – Colombian minister proposes ending Novartis patent

April 26, 2016Statement: Gilead’s Earnings Are Based on Price Gouging Hepatitis C Treatments

April 26, 2016Fort Erie Times: Niagara company offers U.S. cheaper cancer drug

April 26, 2016The Inter-American Dialogue’s daily Latin American Advisor — Q&A with Public Citizen’s Peter Maybarduk

April 12, 2016Common Dreams: Think Medicine is Expensive Now? Public Health Groups Warn of TPP’s Gifts to Big Pharma

April 12, 2016The Hill: Public health groups call for Congress to reject TPP

April 12, 2016NGO Letter to Congress Calling for Rejection of TPP Due to Concerns over Public Health Impacts

April 12, 2016Washington Post: More than 50 health, religious and labor groups urge Congress to reject TPP trade deal

April 6, 2016Huffington Post: Rx for Outrageous Drug Prices: Heal Our Democracy (authored by Public Citizen President Robert Weissman)

April 5, 2016Public Citizen Testimony re: Vermont H.866 – “An act relating to prescription drug manufacturer cost transparency”, Delivered by Steven Knievel before the House Committee on Health Care of the Vermont House of Representatives

April 1, 2016Telemundo: Protestan contra inflación de precios de medicinas

April 1, 2016The Body: Chanting ‘Pharma Greed Kills,’ HIV and Health Justice Groups Protest Across Time Zones and Continents

March 31, 2016Report from Public Citizen’s Health Research Group: Twenty-Five Years of Pharmaceutical Industry Criminal and Civil Penalties: 1991 Through 2015

March 21, 2016Public Citizen and Non-Profit Groups Urge Obama Administration, NIH to Lower Price of Publicly-Funded, $129,000 Per Year Prostate Cancer Drug

March 1, 2016Ministry of Health Resource Page on Imatinib Compulsory License Request

February 27, 2016Submission of Health GAP to the United Nations Secretary-General’s High-Level Panel on Access to Medicines, co-authored by Public Citizen

February 26, 2016Submission of Public Citizen to the United Nations Secretary-General’s High-Level Panel on Access to Medicines

February 24, 2016Kentucky Center for Investigative Reporting: Drug Company Lobbying Has Doubled In Kentucky In Recent Years

February 18, 2016Public Citizen, Health Action International & Commons Network Position Statement on TTIP and Access to Medicines — available in Spanish here

February 17, 2016Technical Committee Declares Cancer Medicine Imatinib (Glivec) to be of Public Interest, Paving Way for a Compulsory License

February 11, 2016plus: Is There Still Time to Stop This Threat to the Global HIV Effort?

February 6, 2016Scrips Howard: Protesters Say Medicines Will be Unaffordable with TPP

February 6, 2016Video: Cancer Patients Arrested at World Cancer Day Protest

February 5, 2016Public Citizen Comments for USTR’s 2016 Special 301 Review

January 1, 2016Modern Healthcare: High drug prices will be a big political issue in 2016

December 19, 2015New York Times Editorial Board: No Justification for High Drug Prices

December 17, 2015StatNews: For drug companies, the Martin Shkreli nightmare isn’t over yet

December 17, 2015AP: Exec who jacked up price of a lifesaving drug is arrested

December 16, 2015In These Times: 8 Terrible Things About the Trans-Pacific Partnership

December 14, 2015AboutLawsuits.com: House “Orphan” Drug Law Proposal Criticized In Public Citizen Report

December 9, 2015Public Citizen Health Advocate Vijay Das on CNN: Congress, don’t fall for Big Pharma’s gimmick

December 9, 2015Wall Street Journal: How Pfizer Set the Cost of Its New Drug at $9,850 a Month

December 8, 2015StatNews’ Pharmalot: Bill creating more orphan drugs would cost taxpayers and patients

December 8, 2015Regulatory Affairs Professional Society: Consumer Advocacy Group Warns on Orphan Provisions in ‘Cures’ Act

December 8, 2015Wall Street Journal: 5 Things to Know About How Drug Prices Are Set

December 8, 2015Press Release: Orphan Medication Proposal: A Windfall for Pharma, False ‘Cure’ for Patients

December 8, 2015Video: Public Citizen’s Maybarduk Testifies at the House Ways & Means Democrats’ Hearing on the TPP and Access to Medicines

December 8, 2015Public Citizen Testimony Before House Committee on Ways and Means Democrats’ Hearing on the Trans-Pacific Partnership and Access to Medicines

December 1, 2015Washington Post: How an $84,000 drug got its price: ‘Let’s hold our position … whatever the headlines’

November 28, 2015The Economist: Billion-dollar babies

November 26, 2015The Salt Lake Tribune: Once an Obama ally on trade deal, Utah’s Hatch may fight latest proposal

November 25, 2015CBS News: Turing cuts 5,000% drug price hike to 2,500%

November 25, 2015Factsheet: How the TPP Endangers Access to Affordable Medicines (updated November 2015)

November 25, 2015Memo: TPP vs. Access to Medicines in Developing Countries; TPP Rolls Back “May 10th Agreement” Reforms (updated November 2015)

November 25, 2015Memo: Three Burning Questions about the TPP Transparency Annex and Its Implications for U.S. Health Care (updated November 2015)

November 19, 2015Memo: Ambiguity Leads to Fallacy: Biologics Exclusivity in the Trans-Pacific Partnership (updated November 2015)

November 16, 2015Memo: TPP Transition Periods: Bad Rules Comming Soon in a TPP Country Near You (updated November 2015)

November 5, 2015Memo: The Highlights of the Trans-Pacific Partnership E-commerce Chapter (coauthored with Tamir Israel of Canadian Internet Policy & Public Interest Clinic — CIPPIC)

November 5, 2015Press Release: TPP Text Reveals Risk for Consumer Privacy Reform

October 9, 2015Public Citizen Analyses of Final Text of TPP IP Chapter Published by WikiLeaks

October 6, 2015Science Mag: Trade agreement praised and panned

October 6, 2015 – Democracy Now on the TPP with segments featuring Public Citizen President Robert Weissman and Affordable Cancer Medicine Activist Zahara Keckscher

October 5, 2015Marketplace: In the end, the real hurdle to a TPP deal was drugs

October 5, 2015Vox: How the Trans-Pacific Partnership could drive up the cost of medicine worldwide

October 5, 2015NPR: This We Do Know About TPP: The Shouting Is Already Loud

October 5, 2015What Changes Lie Ahead From the Trans-Pacific Partnership Pact

October 5, 2015Statement: Eleventh Hour #TPP Deal on Biotech Drugs Still Harms Access to Medications

October 4, 2015New York Times: As Pacific Trade Negotiators Haggle, U.S. Officials Remain Hopeful

October 4, 2015Wall Street Journal: U.S., Australia Agree on Complicated Compromise on Biologic Drugs

October 3, 2015Washington Post: Fierce split over next-generation drugs holds up Pacific Rim trade talks

October 3, 2015New York Times: Negotiations on Trans-Pacific Trade Pact Are Extended, Fueling Hope

October 2, 2015Los Angeles Times: Trade talks over Pacific Rim deal appear headed to a third day

October 2, 2015Letter from Members of Congress to Froman Asking USTR to Support LDC TRIPS Transition Period Extension

October 1, 2015The Malaysian Insider: TPP trade talks narrow on tough auto, drug, dairy issues

October 1, 2015Wall Street Journal: Rift Over Drug Protections Complicates Trans-Pacific Partnership Trade Talks

October 1, 2015Japan Times: Ministerial TPP talks kick off, with nations far apart on drug patents

October 1, 2015AARP: Latest TPP Biologics Proposal Is a Step in the Wrong Direction

October 1, 2015MintPress News: Protesting Big Pharma ‘Death Sentence,’ Cancer Patient Arrested Outside TPP Talks

September 30, 2015New York Times: Pacific Trade Deal Talks Resume, Under Fire From U.S. Presidential Hopefuls

September 28, 2015Memo: New TPP Maneuvering on Biotech Drugs: 5+3 Still Makes 8

September 18, 2015IP Watch: Health Advocates Press United States On WTO LDC IP Waiver

September 17, 2015IP Watch: Inside Views: The Lexmark Litigation: Why Does Big Pharma Care So Much About Ink Cartridges?

September 11, 2015Public Citizen & NGOs in Letter to USTR & USPTO Regarding WTO LDC Members’ Request for an Extension of their Pharmaceutical Transition Period

September 3, 2015Baltimore Sun: Public health advocates call on Johns Hopkins to make TB drug widely available

September 2, 2015New York Times Editorial: Costly Hepatitis C Drugs for Everyone?

September 1, 2015The Hill: Sanders to introduce bill targeting high drug prices

August 27, 2015 Entrevista a Mario Rios de Justicia en Salud en el programa Exitosa Noticias

August 27, 2015 Entrevista a Mario Rios de Justicia en Salud en el programa San Borja Noticias

August 22, 2015La Republica: PJ ordena al Minsa informar sobre licencia para Atazanavir

August 20, 2015Journal of the American Medical Association: The Trans-Pacific Partnership Agreement and Implications for Access to Essential Medicines

August 18, 2015IP Watch: Inside Views: Five Reasons Why TPP Countries Should Unite To Oppose The US Pharmaceutical IP Agenda

August 14, 2015Colombia – Acta de no acuerdo Solicitud de licencia voluntaria con Novartis, en español

August 12, 2015Ending AIDS by 2030: Challenges and Opportunities

August 12, 2015Clinical Infectious Diseases: Access to Costly New Hepatitis C Drugs: Medicine, Money, and Advocacy

August 11, 2015Public Citizen Comments to the Office of the U.S. Trade Representative RE: USTR-2015-0009 South Africa AGOA Eligibility (post-hearing)

August 8, 2015The Lancet: The Vancouver Consensus: antiretroviral medicines, medical evidence, and political will

August 6, 2015Public Citizen Comments to the Office of the U.S. Trade Representative RE: USTR-2015-0009 South Africa AGOA Eligibility

August 4, 2015CitizenVox: How Much Is Enough for Gilead?

August 4, 2015Vox: One sentence that explains why Obama is struggling to finish his big trade deal

August 3, 2015New York Times: Trans-Pacific Partnership Session Ends With Heels Dug In

August 3, 2015Journal of Law, Medicine & Ethics: Antibiotic Resistance Is a Tragedy of the Commons That Necessitates Global Cooperation, by Aidan Hollis and Peter Maybarduk

August 1, 2015Al Jazeera English: Pacific trade officials fail to agree on final TPP deal

July 31, 2015Bloomberg: U.S. Said to Drop 12-Year Lock-Up on Biologics Data in TPP Talks

July 31, 2015Reuters: Consumer group warns of drug monopoly under TPP

July 31, 2015Bloomberg: U.S. Bends on Patent Data as Dairy Vexes Pacific Trade Talks

July 31, 2015Reuters:Pacific trade negotiators chase elusive final deal in tough talks

July 30, 2015Al Jazeera America: Trade deal threatens affordable healthcare for millions, experts say

July 30, 2015Global Post: Protesters blow conch shells to demonstrate against TPP trade deal in Maui

July 30, 2015Center for American Progress: Pharmaceutical Provisions of the Trans-Pacific Partnership Threaten Drug Access and Affordability

July 30, 2015Huffington Post – Expanding Medicare System for All Would Eliminate Health Care Rationing (authored by Public Citizen President Robert Weissman)

July 29, 2015GPhA & AARP in Huffington Post: TPP Threatens Access to Affordable Medications for People Around the World

July 29, 2015Public Citizen Report: Additional Exclusivity for Biologic Drugs in the TPP: A Need or Greed?

July 28, 2015Bloomberg: Drug patent dispute emerges as hurdle to Pacific trade deal

July 28, 2015Letter from Rep. Himes to Ambassador Froman Calling for TPP IP Provisions to Balance Innovation and Access to Medicines

July 28, 2015Bloomberg: Pacific Trade Talks Start With U.S. Vow to Solve Toughest Issues

July 28, 2015UNAIDS calls on trade negotiators to uphold governments’ commitments to public health and access to medicines

July 27, 2015AARP to Ambassador Froman: Don’t let the Trans-Pacific Partnership Restrict Access to Affordable Medicine

July 27, 2015IP Watch: Decision Time On Biologics Exclusivity: Eight Years Is No Compromise

July 24, 2015Office of Senator Sherrod Brown: In Advance of Latest Round of TPP Negotiations, Sen. Brown Raises Concerns Over Intellectual Property Chapter and Access to Medicines

July 23, 2015Letter from 11 members of Congress to USTR on the Trans-Pacific Partnership (TPP) and Access to Medicines

July 23, 2015New York Times: Drug Prices Soar, Prompting Calls for Justification

July 17, 2015El Comercio: La salud pública bajo amenaza, por Judit Rius Sanjuan

July 14, 2015La Republica: Licencia obligatoria hubiera permitido 75% de ahorro en Atazanavir

July 14, 2015Journal of the American Medical Association: Senator Urges VA to “Break” Patents for High-Cost Hepatitis C Drugs

July 13, 2015Foreign Affairs: The TPP’s Bad Medicine

July 13, 2015La Republica: Bristol rebaja en 35% precio de fármaco contra el VIH, pero no deja el monopolio

July 13, 2015Bolsamania: Antirretroviral Atazanavir cuesta 35% menos hoy que ayer pero aún es muy caro en Perú

July 10, 2015Bloomberg: Obama Pushes Trade Partners to Add Drug Rules He Opposes in U.S.

July 8, 2015IP Watch: TISA Stocktaking Meeting Also Might Have To Face Growing Protests

July 7, 2015Forbes: TPP Still Has A Long Way To Go

July 2, 2015Ars Technica: WikiLeaks drops new set of secret TISA docs: Yep, no one agrees

July 2, 2015Analysis: Leaked TISA Annex on Electronic Commerce (Burcu Kilic, Public Citizen & Tamir Israel, Canadian Internet Policy & Public Interest Clinic)

July 1, 2015Politico: Leaked: What’s in Obama’s trade deal

June 25, 2015Wall Street Journal: Fast-Track’s Passage Sets Up Round Two on Obama’s Trade Agenda

June 24, 2015New York Times: President Obama Must Use Trade Authority to Reach Better Agreements

June 24, 2015Politico: Trade talks approach endgame with fast track passage

June 24, 2015Financial Times: Obama’s big Pacific trade gambit: What comes next

June 23, 2015Letter from Alianza in support of Ecuador’s proposed Law on the Social Economy of Knowledge (COESC)

June 19, 2015Wall Street Journal: Will the controversial Trans-Pacific Partnership trade agreement really be bad for your health?

June 19, 2015Financial Times: Congress’s fast track to discord on free trade

June 18, 2015Health and Human Rights Journal: The Trans-Pacific Partnership and Access to Medicines

June 18, 2015Wall Street Journal: House Passes Fast-Track Trade Bill

June 16, 2015New York Times: House Moves to Delay Action on Trade Bill for 6 Weeks

June 15, 2015Washington Post: US fast-track vote leaves Pacific trade pact talks in limbo

June 12, 2015Healthline: Would the Trans Pacific Partnership Boost Drug Prices and Endanger Access?

June 12, 2015Bloomberg: Rep. Levin: U.S. Trade Policies Aren’t on the Right Track

June 12, 2015Public Citizen’s Global Access to Medicines Program in The Hill: Leaks show trade deal undermines Obama’s proposed healthcare reforms

June 11, 2015plus: People With HIV May be the Biggest Losers Under New Trade Treaty

June 11, 2015Public Citizen’s Global Access to Medicines Program Director Peter Maybarduk on Democracy Now: Backlash Against TPP Grows as Leaked Text Reveals Increased Corporate Control of Public Health

June 10, 2015La Republica: Perú perderá soberanía en salud y se expondrá a juicios de farmacéuticas

June 10, 2015Memo: Three Burning Questions about the Leaked TPP Transparency Annex and Its Implications for U.S. Health Care

June 10, 2015Press Release: Latest TPP Leak Raises Burning Questions About Implications for U.S. Health Care System

June 10, 2015New York Times: U.S. Shifts Stance on Drug Pricing in Pacific Trade Pact Talks, Document Reveals

June 10, 2015WikiLeaks: TPP Transparency Chapter: Annex on Transparency and Procedural Fairness For Pharmaceutical Products and Medical Devices

June 10, 2015MarketPlace: What Big Pharma wants from the big trade deal

June 10, 2015Perú perderá soberanía en salud y se expondrá a juicios de farmacéuticas

June 5, 2015IP Watch: Confidential USTR Emails Show Close Industry Involvement In TPP Negotiations

May 28, 2015Rep. Sander Levin: Is TPP the Most Progressive Trade Agreement in History? Not If You Need Access to Affordable Medicines

May 27, 2015Financial Times: Free Lunch: Trans-Pacific opacity

May 27, 2015The Guardian: Here’s how much corporations paid US senators to fast-track the TPP bill

May 27, 2015New York Times: H.I.V. Treatment Should Start at Diagnosis, U.S. Health Officials Say

May 26, 2015The Washington Times: Obama’s Asia trade deal faces mounting opposition in House

May 22, 2015Paul Krugman in the New York Times: Trade and Trust

May 21, 2015Wall Street Journal: Bristol-Myers Faces a Compulsory License for an AIDS Drug in Peru

May 20, 2015MedPage Today: Could Trans-Pacific Partnership Place Drugs Out of Reach?

May 18, 2015Letter from Joseph Stiglitz to Members of Congress: Where Progressive and Conservatives Agree on Trade: Current Investor-State Dispute Settlement model is bad for the United States

May 13, 2015Financial Times: Senate compromise gives Obama ‘fair’ Pacific trade deal

May 12, 2015New York Times: Senate Democrats Foil Obama on Asia Trade Deal

May 12, 2015Sanders Urges VA to Use Emergency Powers to Save Lives of Veterans with Liver Disease (Press Release from Office of Sen. Sanders; see the letter from Sen. Sanders to Sec. McDonald here)

May 12, 2015Global Post: This US-backed Pacific trade deal could stop the poor from getting life-saving meds

May 8, 2015amfAR: Trans-Pacific Partnership: Curbing Access to Medicines Now and in the Future

May 5, 2015Memo: Accion Judicial de Bristol-Myers Squibb Respecto al Atazanavir

May 5, 2015New York Times Editorial: Runaway Drug Prices

April 28, 2015Public Citizen and IFARMA letter to INDECOPI on compulsory licensing

April 28, 2015Civil society letter to Peruvian officials on atazanavir compuslory license (available in English here)

April 28, 2015Academics letter to Peruvian officials on atazanavir compuslory license (available in English here)

April 24, 2015IP Watch: Inside Views: Divide And Conquer: The New US Strategy To Disentangle The TPP Negotiations

April 22, 2015New York Times: Newt Gingrich: Double the N.I.H. Budget

April 21, 2015Statement: California Legislature Should Pass Bill Requiring Greater Transparency from Pharmaceutical Companies

April 14, 2015Letter: Knowledge Ecology International and Public Citizen ask the NIH for safeguards in patent license for HCV drug

April 10, 2015Public Citizen in the Harvard Human Rights Journal: Freeing Trade at the Expense of Local Crop Markets?: A Look at the Trans-Pacific Partnership’s New Plant-Related Intellectual Property Rights from a Human Rights Perspective

April 9, 2015Public Citizen’s Burcu Kilic and Pablo Viollier in El Mostrador: Opinión: Divide y vencerás, la nueva estrategia de Estados Unidos para destrabar las negociaciones del TPP (en español)

April 8, 2015Public Citizen in the Yale Journal of International Law: What Is Patentable Under the Trans-Pacific Partnership? (full article)

March 30, 2015Investor-State Attacks on Public Interest Policies: Access to Medicines; ISDS: Enforcer for Big Pharma Wish List; Health at Stake

March 27, 2015amfAR: The High Cost of Free Trade for People Living with HIV in the Asia-Pacific

March 25, 2015The New York Times: Trans-Pacific Partnership Seen as Door for Foreign Suits Against U.S.

March 25, 2015The Financial Times: The flaws in the geopolitical case for the TPP

March 20, 2015Coalition Statement: EU trade secrets directive threat to health, environment, free speech and worker mobility

March 11, 2015Krugman in the New York Times: TPP at the NABE

March 6, 2015Rep. Jan Schakowsky & Public Citizen’s Global Access to Medicines Director Maybarduk in The Hill: US trade policy could raise drug prices, at home and abroad

March 5, 2015ANEPI interview with Global Access to Medicines Program Director Peter Maybarduk; “Licencias obligatorias no deben ser controversiales”

March 2, 2015New York Times Editorial: Congress’s Critical Role on Trade

February 17, 2015Interfaith Working Group on Trade letter urging Congress to oppose Fast Track

February 13, 2015The Star Online: Malaysian, other health professionals fear higher health cost after Pacific pact

February 12, 2015Reuters: Doctors warn of healthcare impact from Pacific trade pact

January 30, 2015Joseph Stiglitz in the New York Times: Don’t Trade Away Our Health

January 26, 2015Public Citizen Global Access to Meds in the New York Times: Contrasting Perspectives on the Price of Medicines

January 25, 2015Public Citizen and Others in Letter to Obama: Promote Health In India Not Narrow Pharma IP Interests (links to healthgap.org)

December 18, 2014 – Public Citizen Report: Competition Inhibitors: How Biologics Makers Are Leveraging Political Power to Maintain Monopolies and Keep Prices Sky-High

Read the press release on the report here

December 17, 2014Press Release: Leak of Obama Administration Trade Pact Proposal Reveals Negotiations Affecting Net Neutrality, Limits on Data Privacy Protections

December 17, 2014Report: Proposal of New Provisions Applicable to All Services of the secret TISA negotiations

December 17, 2014Coalition Statement: EU trade secrets directive threat to health, environment, free speech and worker mobility (updated March 20, 2015)

December 3, 2014Press Release: Government Action Needed to Slash Prices for Hepatitis C Treatments
Read the testimony from Public Citizen President Rob Weissman here.

November 17, 2014Letter sent to President Ollanta Humala of Peru requesting a compulsory license on the HIV medication atazanavir in Peru

November 17, 2014Letter sent to Ministry of Health of Peru requesting a compulsory license on the HIV medication atazanavir in Peru

October 16, 2014Public Citizen analyses of the new WikiLeaks TPP IP text

October 2, 2014Public Citizen Chart summarizing history of compulsory licensing in Ecuador

September 2, 2014One Step Forward, One Step Back – Ecuador issues new, pro-health compulsory licenses, but signs harmful trade agreement with the European Union (available in Spanish here)

August 14, 2014LaRepublica.pe – Sobregasto en medicamentos (en español)

July 17, 2014NPR: Evaluating The Benefits And Costs Of Patents (links to npr.org)

July 15, 2014Livemint: Bombay HC upholds Nexavar compulsory licensing decision (links to livemint.com)

July 14, 2014MSF: TPP: Still a Terrible Deal for Poor People’s Health(links to huffingtonpost.com)

July 7, 2014Op-ed: The TPP could be a blow to public health (links to ottawacitizen.com)

June 25, 2014Video of Global Access to Medicines Program Director Peter Maybarduk’s presentation at the Transatlantic Consumer Dialogue event on IP in TAFTA

June 23, 2014Videos, summaries, photos and more from the June 5 briefing on the Eli Lilly v. Canada investor-state case and secondary pharmaceutical patents

May, 2014Presentation: Confidential Commercial Information vs. Our Right to Know

May 27, 2014CitizenVox: Public Citizen Joins Partners in Calling for Action Against Antibiotic Resistance

May 25, 2014Public Citizen News: Working for Big Pharma: U.S. Government Pressures Developing Countries

May 22, 2014 Public Citizen and members of the Antibiotic Resistance Coalition calls on World Health Organization Member States to pass critical resolution

Learn more about antibiotic resistance and the Antibiotic Resistance Coalition’s work.

May 15, 2014Boehringer Ingelheim’s response to Public Citizen’s letter regarding the Medicines Patent Pool

See our Medicines Patent Pool resource page for more resources.

May 1, 2014The Times of India: Ten emerging economies targeted by US for IP violation, India’s inclusion widely criticized

May 1, 2014The Economic Times: US not placing India under the punitive Priority Foreign Country most sensible thing to do: Experts

May 1, 2014The Economic Times: Did US baulk at prospect of upsetting the next government on IPR?

May 1, 2014SpicyIP: Special 301 Report: India not downgraded to Priority Foreign Country, will receive OCR though

April 30, 2014Infojustice: USTR Avoids India’s WTO Threats to Special 301

April 30, 2014Statement: U.S. Chamber, Big Pharma Miss Their Target on India Trade, But U.S. Watch List Still Bullies India, Other Developing Countries Over Health Policies

See more about U.S. pressure against countries’ public interest policies.

April 29, 2014Truthout: Hand in Hand With US Government, Big Pharma Pushes for More Profits

April 25, 2014Novartis’ response to Public Citizen’s letter regarding the Medicines Patent Pool

April 23, 2014Johnson & Johnson’s response to Public Citizen’s letter regarding the Medicines Patent Pool

See our Medicines Patent Pool resource page for more resources.

April 18, 2014Presentation at Johns Hopkins Bloomberg School of Public Health: Ensuring Safety and Access, or Thinking Usefully About Counterfeits

April 17, 2014Peruvian Civil Society Organizations Demand that Government Issue a Compulsory License for Atazanavir (links to infojustice.org)

April 15, 2014Business Standard: Indian laws should not be considered discriminatory: Group (links to business-standard.com)

April 11, 2014Public Citizen Comments to the United States International Trade Commission Re: Investigation No. 332-543, Trade, Investment, and Industrial Policies in India: Effects on the U.S. Economy

April 8, 2014 – Public Citizen letters to AbbVie, Boehringer-Ingelheim, Bristol-Myers Squibb, F. Hoffman-La Roche, Gilead, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Pfizer and Shionogi regarding the latest licensing agreement between ViiV Healthcare and the Medicines Patent Pool

See our Medicines Patent Pool resource page for more statements.

April 8, 2014Rep. Raul Grijalva and Global Access to Medicines Program Director Maybarduk in the Huffington Post: The Trans-Pacific Partnership Is terrible for Public Health (links to huffingtonpost.com)

April 1, 2014Medicines Patent Pool-ViiV Healthcare Licensing Agreement Statement of Peter Maybarduk, Global Access to Medicines Program Director

See our Medicines Patent Pool resource page for more statements.

March 31, 2014Public Citizen’s Global Access to Medicines Program letter to the editor of the New York Times: How Public Research Underpins Private Health Care (links to nytimes.com)

March 20, 2014Letter from members of Congress requesting Gilead CEO to justify pricing of Hepatitis C drug Solvadi

March 14, 201416 members of Congress write USTR expressing concern over TPP provisions’ effect on access to medicines

March 14, 2014Sunlight Foundation: How Big Pharma (and others) began lobbying on the Trans-Pacific Partnership before you ever heard of it

February 27, 2014Krugman NYT Op-ed: No Big Deal (links to nytimes.com)

February 24, 2014Public Citizen Comments for USTR’s 2014 Special 301 Review. See the video of Global Access to Medicines Program Director Peter Maybarduk’s testimony here.

February 24, 2014BBC: US-India relations suffer in trade spat over cheap drugs (links to bbc.com)

February 12, 2014-Coalition Statement: Access to medicines coalition takes a joint stance against USTR’s “new” approach for addressing access to medicines in developing countries in the TPP

February 11, 2014National Journal: The Last Major Fault Line in the Democratic Party (links to nationaljournal.com)

February 10, 2014New York Times: Poor Nations Seek New Hepatitis C Drug (links to nytimes.com)

February 5, 2014AIDS Activists say Merck walking all over South Africans for profit (links to stopaids.org.uk)

February 4, 2014BBC: Do drugs really have to be so expensive? (links to bbc.co.uk)

January 27, 2014Health Affairs Blog: Don’t put the brake on ending AIDS (links to healthaffairs.org)

January 17, 2014Several ranking members in Congress send letter to USTR in support of access to medicines in developing countries

January 17, 2014Mail and Guardian: Motsoaledi: Big pharma’s ‘satanic’ plot is genocide (links to mg.co.za)

January 16, 2014The Guardian: South African pharma firms accused of planning to delay patents law reform (links to theguardian.com)

January 11, 2014HuffingtonPost: Why House Democrats Might Kill Obama’s Big Trade Deal (huffingtonpost.com)

January, 2014Updated Analysis: Dangers for Medicine Prices and Local Innovation in the Trans-Pacific Partnership Agreement (TPP): Comparative Analysis of the United States’ Intellectual Property Proposal and Japanese Law, Dr. Burcu Kilic, Mi Kyoeng Kim & Peter Maybarduk, January 2014

December 23, 2013The Pharma Letter: Ukraine government introduces compulsory licensing for pharma products (links to www.thepharmaletter.com)

December 18, 2013Washington Post: Obama administration sued over its secretive trade negotiations (washingtonpost.com)

December 12, 2013Medicines Patent Pool Reaches Licensing Deal with BMS to Expand Access to AIDS drug (links to citizen.org)

December 9, 2013KEI: 6 Members of Congress Write to President Obama on TPP and Access to Health Care, Criticize Closed Door Negotiations (links to keionline.org)

December 9, 2013KEI: 29 Organizations and More than 70 Individuals Sign Letter Opposing Life Plus Seventy Year Copyright Term in TPP (links to keionline.org)

December 6, 2013Representative Waxman sends letter to USTR expressing strong disagreement with 12 years of data exclusivity in the TPP (links to waxman.house.gov)

December 5, 2013Vatican criticizes TRIPS+ and ISDS provisions in FTAs at WTO Ministerial Conference (links to wto.org)

November 27, 2013US’s Proposed TPP Transition Period for Middle-Income Parties is Fools Gold (links to healthgap.org)

November 26, 2013Washington Post: Here’s why Obama trade negotiators push the interests of Hollywood and drug companies (links to washingtonpost.com)

November 24, 2013The Globe and Mail: Canada must learn from NAFTA legal battles (links to theglobeandmail.com)

November 24, 2013Scoop: Outrageous US bullying on IP and Health at TPPA Talks (links to scoop.co.nz)

November 19, 2013Congresswoman Barbara Lee Hails Passage of Bipartisan PEPFAR Stewardship Act (links to lee.house.gov)

November 19, 2013Financial Times: Global spending on drugs to exceed $1tn (links to ft.com)

November 18, 2013Desmond Tutu in Politico: Two Steps Obama Can Take to Defeat AIDS (links to politico.com)

November 13, 2013Public Citizen: Leaked Documents Reveal Obama Administration Push for Internet Freedom Limits, Terms That Raise Drug Prices in Closed-Door Trade Talks

November 13, 2013NYTimes: House Stalls Trade Pact Momentum (links to nytimes.com)

November 12, 2013Pharmalot: What Patent Reform in Brazil and South Africa Can Mean (links to pharmalive.com)

November 9, 2013PBS: Maine’s Prescription for drug savings: Go foreign

November 8, 2013Eyes on Trade: 38 Million Retirees Join Workers and Consumers to Say No to “Trade” Deal Terms that Would Make Medicine More Expensive

November 8, 2013Counter Punch: The Withering of Big Pharma?

November 7, 2013Knowledge Ecology International: NIH rejects March-In petition, also rejects proposed rules on pricing of and access to government funded inventions

November 3, 2013Naked Capitalism: The Global Corporatocracy is Almost Fully Operational

October 28, 2013PAHO: Countries of the Americas choose innovative projects for the development of drugs and technologies

October 21, 2013Reuters: Ending drug trial secrecy is a boon for R&D, says EU agency

October 11, 2013The Hindu Business Line: What the Doctor Ordered

October 10, 2013The Hill: Drug makers try to outflank White House in trade agreement

October 9, 2013Dissent: Patents Against People How Drug Companies Price Patients out of Survival

September 26, 2013Politico: President Obama to dive into Pacific trade talks

September 21, 2013The Post Online: Lack of access to essential medicines, new technologies worries Ban

September 12, 2013Politico: Eli Lilly sues Canada on drug patents

September 9, 2013WUNC:Duke Institute Looks for New Ideas in Access to Medicine

August 29, 2013The New York Times: The Hazard of Free-Tr

August 23, 2013The New York Times: Why is Obama Caving on Tobacco? (links to nytimes.com)

July 29, 2013The New England Journal of Medicine: Engineered in India – Patent Law 2.0 (links to yale.edu)

July 14, 2013The New York Times: How Intellectual Property Reinforces Inequality (links to nytimes.com)

July 12, 2013Patrick Leahy: Leahy Urges Action To Ensure Access To Affordable Life-Saving Diagnostic Tests For Breast And Ovarian Cancer (links to senate.gov)

July 11, 2013U.S. PIRG: Top Twenty Pay-For-Delay Drugs (links to uspirg.org)

July 8, 2013Citizen Vox: Public Citizen welcomes the Marrakesh Treaty for the Blind (links to citizenvox.com)

June 28, 2012Global Post: Historic Treaty Signed Giving Blind Better Books Access (links to globalpost.com)

June 27, 2013Public Citizen: India’s Patent System Plays by WTO Rules and Supports Global Health (links to citizen.org)

June 19, 2013Citizenvox: Reversing the “IP Ratchet : Global Implications of the U.S. Supreme Court’s Ruling in Myriad (links to citizenvox.org)

June 18, 2013Huffington Post: Alan Grayson on Trans-Pacific Partnership: Obama Secrecy Hides ‘Assault on Democratic Government’ (links to huffingtonpost.com)

June 10, 2013The Guardian: Poorest countries eye additional grace period on intellectual property issues (links to guardian.co.uk)

June 10, 2013The Guardian: Poorest countries eye additional grace period on intellectual property issues (links to guardian.co.uk)

June, 2013International Centre for Trade and Sustainable Development: El Acuerdo de Asociación Transpacífico en la política comercial chilena (links to ictsd.org)

June 2, 2013Scoop: Chile’s ex-chief negotiator drops a bombshell on TPPA (links to scoop.co.nz)

June 2, 2013The New York Times: Obama’s Covert Trade Deal (links to nytimes.com)

May 30, 2013The Jakarta Globe: Future Hepatitis C Blockbusters May Spawn Compulsory Generics (links to the jakartaglobe.com)

May 23, 2013New Vision: Civil Society groups petition US, EU over WTO TRIPS Agreement (links to newvision.co.ug)

May 20, 2013Huffington Post: TRIPS Exemption Opposed by Obama Administration, Threatening Cost Spike for Drugs in Poorest Nations (links to huffingtonpost.com)

May 18, 2013Huffington Post Canada: Why Are We Bullying the World’s Poorest Countries? (links to huffingtonpost.ca)

May 17, 2013Tech Dirt: Big Pharma Firms Seek .pharmacy Domain To Crowd Out Legitimate Foreign Pharmacies (links to techdirt.com)

May 15, 2013The Atlantic: How Drug Companies Keep Medicine Out of Reach (links to theatlantic.com)

May 15, 2013Members of Congress urge USTR to support request from least developed countries for a TRIPS waiver extension

May 14, 2013 The New Nation: US, EU urged to keep TRIPS waiver open (links to thenewnation.bd.com)

May 12, 2013Slate: Gene patents: The case of Myriad Genetics shows the dangers of overly protecting intellectual property rights (links to slate.com)

May 2, 2013CitizenVox: US Government’s “Watch List” on Developing Countries Health Rights (links to citizenvox.com)

May 1, 2013The New York Times: Exorbitant Prices for Cancer Drugs (links to nytimes.com)

April 25, 2013Blood Journal: Prices of drugs for chronic myeloid leukemia (CML), reflection of the unsustaintable cancer drug prices: perspective of CML experts (links to bloodjournal.hematologylibrary.org)

April 25, 2013New York Times: Doctors Denounce Cancer Drug Prices of $100, 000 A Year (links to nytimes.com)

April 23, 2013Wall Street Journal Op-Ed: Must All Patents Last for 20 Years? (links to online.wsj.com)

April 23, 2013Johnson & Johnson response to Public Citizen letter on the Medicines Patent Pool

April 22, 2013Bristol-Myers Squibb response to Public Citizen letter on the Medicines Patent Pool

April 2, 2013 – Public Citizen letters to Abbott Laboratories, Boehringer-Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck & Co. and Pfizer regarding the ViiV Healthcare and Medicines Patent Pool Agreement

April 1, 2013 Analysis: India’s Supreme Court Upholds Strict Patent Standards and Patients’ Right to Access to Affordable Medicines; Court dismisses unmeritorious court challenge by drug giant

April 1, 2013Patent’s defeat in India is Key Victory for Generic Drug

April 1, 2013Novartis Cancer-Drug Patent Denied by India Supreme Court

March 28, 2013BBC News: Do drugs really have to be so expensive? (links to bbc.co.uk)

March 18, 2013Public Citizen press release: Winners of ACTA and SOPA Battles Call for Exclusion of ‘Intellectual Property’ From EU-U.S. Trade Talks

March 18, 2013Essential Inventions issues request for non-voluntary authorization to use patents under Article 14 of Greece patent law (links to essentialinventions.org)

March 17, 2013The Nation: Avoid Mistakes of the West: Stiglitz (links to nationmultimedia.com)

March 17, 2013Bangkok Post: Stiglitz warns not to expect a quick global recovery (links to bangkokpost.com)

March 8, 2013Third World Network: South Support LDCs’ transition period, North creates obstacles (links to twn.my)

March 4, 2013Doctors Without Borders Press Release: As Clock Ticks Towards Trans-Pacific Trade Pact Deadline, U.S. Must End Stall Tactics on Access to Medicines

March 4, 2013Wall Street Journal: India Appeals Body Rejects Bayer’s Plea on Nexavar (links to wsj.com)

February 28, 2013-Info Justice: Detailed Analysis of the Medicines Patent Pool– ViiV Pediatric ARV License and Memorandum of Understanding (links to infojustice.org)

February 28, 2013HuffPost Live: Prescriptions to Die Live Segment, Featuring Global Access to Medicines Director Peter Maybarduk

February 28, 2013Press Release: Medicines Patent Pool Reaches Licensing Deal for GSK Patents to Expand Access to Medicines for Children with HIV

February 27, 2013Reuters: GlaxoSmithKline unit joins patent pool for AIDS drugs (links to reuters.com)

February 26, 2013KEI Online: The US Department of Justice and USPTO call for compulsory licenses on thousands of “standards-essential patents” (links to keionline.org)

February 6, 2013Huffington Post: Patent Reform, System Should Be Abolished, Fed Economists Say (links to huffingtonpost.com)

January 9, 2013Wall Street Journal: The TPP would be a bitter pill (links to online.wsj.com)

December 18, 2012Dawson Strat: The Problem of Patent Protection (links to dawsonstrat.com)

December 6, 2012Ars Technica: Staffer axed by Republican group over retracted copyright-reform memo (links to arstechnica.com)

December 5, 2012Open Society Foundations blog post by Access to Medicines Director Peter Maybarduk: Trans-Pacific Partnership: Closed Negotiations Against the Knowledge Economy

December 4, 2012Press Release: Digital Rights and Health Experts Frustrated by New Rule To Shut Out Civil Society from TPP Negotiation Venue

December 3, 2012Scoop: Press Release from Jane Kelsey: Lockout of Stakeholders from TPP Negotiations (links to scoop.co.nz)

November 11, 2012Pharmac Annual Report: Pharmac says its work has saved district health boards more than $5 billion over the past 12 years

November 9, 2012Leesburg Patch: Letter to the Editor by Access to Medicines Director Peter Maybarduk: Medicines Monopoly (links to leesburg.patch.com)

November 5, 2012Irin News:South Africa: Easy patents cost patients (links to irinnews.org)

November 2, 2012Press Release: Patients succeed in overturning first ever product patent on medicine in India (links to kractivist.wordpress.com)

October 30, 2012Knowledge Ecology International: How common is Federal Funding of patented inventions? (links to keionline.org)

October 25, 2012Knowledge Ecology International: Four NGOs ask NIH to grant open licenses to ritonavir patents under Bayh-Dole March-in provisions (links to keionline.org)

October 23, 2012ACLU: Get Ready for A Scintillating Discussion on the Finer Points of IP and Foreign Trade Policy (links to aclu.org)

October 14, 2012New York Times: In Cancer Care, Cost Matters (links to nytimes.com)

October 11, 2012Press Release: Indonesian Government Takes Bold Stance to Reduce Costs of AIDS Medications, Potentially Saving Thousands of Lives (links to citizen.org)

October 11, 2012The Guardian: Indonesia in bold move to obtain cheap drugs for HIV (links to guardian.co.uk)

October 9, 2012Wall Street Journal: Letter to the Editor by Global Access To Medicines Director, Peter Maybarduk: Compassion, Risk and IP Protection

September 26, 2012 Public Citizen’s Global Access To Medicine Program: Comparative Table of Patent Linkage Provisions in U.S. Free Trade Agreements and the U.S. Proposal to the Trans-Pacific (TPP) Agreement

September 6, 2012Amnesty International Press Release: TPP Must Not Trade Away Free Speech and Health (links to amnesty.org)

September 6, 2012Wall Street Journal: TPP Too Secretive, Damaging to Digital Rights, Public Interest Groups Say (links to professional.wsj.com)

September 5, 2012Telephone Briefing: What TPP Means for Digital Rights and Patients’ Rights, listen to Public Citizen’s Peter Maybarduk (2:26)

September 4, 2012Nature: Trade deal to curb generic-drug use (links to nature.com)

August 29, 2012ACLU: The Biggest Threat to Free Speech and Intellectual Property That You’ve Never Heard Of (links to aclu.org)

August 28, 2012Civil Society Groups Oppose US and Australia’s TPP Proposal on Exceptions and Limitations (links to eff.org)

August 28, 2012The Wall Street Journal House Democrats Call On Administration To Open Trade Talks-Request Access as Observers to Trans-Pacific Partnership Negotiations

August 27, 2012The Guardian: The Pacific free trade deal that’s anything but free (links to guardian.co.uk)

August 24, 2012Public Knowledge & Public Citizen: Intellectual Property in the TPP: How About a Little Balance (links to publicknowledge.org)

August 22, 2012Bangkok Post: Data exclusivity a life and death issue (links to bangkokpost.com)

August 19, 2012Wall Street Journal: Novartis Fights India for Cancer Pill Patent (links wsj.com)

August 17, 2012The Hindu Business Line: Cipla bats for automatic compulsory licensing (link to thehindubusinessline.com)

August 8, 2012Business Week: AIDS Sufferers Seen Hurt in Pacific Trade Pact Limits (links to businessweek.com)

August 7, 2012 – Pfizer agrees to pay $15 million penalty to resolve foreign bribery investigation
Court DocumentsInformation | Deferred Prosecution Agreement

August 7, 2012Pharmalot: Malaysia Objects to Patent Terms in Trade Deal (links to pharmalot.com)

July 30, 2012Calling for an “AIDS free generation” but trading away our lives (links to Citizen News Service)

July 30, 2012The Most Important Trade Agreement That We Know Nothing About (links to Slate)

July 25, 2012Interview with Global Access to Medicines Program Director Peter Maybarduk (links to Radio Australia)

July 24, 2012Rep. Henry Waxman: More work needs to be done on HIV (links to Politico)

July 24, 2012International AIDS Conference Sparks Protest of Obama Trade Policies (links to Huffington Post)

July 23, 2012Press Release: Obama Trade Pact Could Impede “AIDS-free Generation”

July 22- 27, 2012-The 19th International AIDS Conference in Washington D.C.

July 21, 2012We Can End AIDS: Join Us this Tuesday in Washington, D.C.

July 20, 2012Ending the HIV/AIDS Epidemic Act of 2012 Introduced; Aims to Protect Flexible IP Policies that Promote Access to Medicines (links to infojustice.org)

July 19, 2012Thailand Urged to Reject Gilead AIDS Drug Patents (links to Pharmalot)

July 18, 2012Patents limiting access to anti-retroviral drugs used to treat HIV (links to The Global and Mail)

July 13, 2012Kaiser Family Foundation: Trade Agreements Could Harm Access To Antiretroviral Drugs In Asia, Pacific, Experts And Activists Warn

July 10, 2012HuffPo: Poison Pills, While Cutting Costs At Home, Obama Administration Pushes Higher Drug Prices On World’s Poor (link to huffingtonpost.com)

July 2-10, 2012Round 13 of TPP negotiations in San Diego, CA, USA

June 29, 2012Joint Statement from Malaysian health advocacy groups against the Trans-Pacific Partnership Agreement

June 29, 2012infojustice.org: Issa, Canada, and Mexico All Denied TPP Observer Status; Congress Continues to Seek Greater Transparency (links to infojustice.org)

June 28, 2012Huff Po: In Other News, Obama Admin to Block Access to Affordable Cancer Drugs in Developing Countries (links to Huffington Post)

June 28, 2012Techdirt: Over 130 Representatives Spell Out their Concerns with TPP in Letter to Ron Kirk (links to Techdirt)

June 27, 2012Public Citizen Global Trade Watch’s Lori Wallach: NAFTA on Steroids (links to The Nation)

June 27, 2012Press Release: Congressional Democrats Escalate Criticism of Substance, Process of Obama’s 1st Trade Pact – the TPP

June 27, 2012With Proposed NAFTA-Style Trade Deal Threatening to Undermine American Auto and Manufacturing Jobs, Brown Joins Business & Labor Leaders to Announce Efforts to Reform Trade Agreements (links to Sherrod Brown Congressional Website)

June 25, 2012With Trans-Pacific Partnership Negotiations Set to Continue in California Next Week, Senators Call for Increased Transparency, Including Broader Consultation on Internet Freedom (links to Sherrod Brown Congressional Website)

June 21, 2012The Trans-Pacific Partnership: “Can you say ‘Déjà vu’ in Spanish?” (links to CitizenVox)

June 21, 2012BBC News: European trade committee votes to reject piracy treaty (links to BBC News)

June 20, 2012The Trans-Pacific Partnership: “Just Relax Canada, U.S. Pharma Will Handle It” (links to CitizenVox)

June 19, 2012USTR Kirk Welcomes Canada as New Trans-Pacific Partnership Negotiating Partner (links to USTR.gov)

June 18, 2012USTR Kirk Welcomes Mexico as a New Trans-Pacific Partnership Negotiating Partner (links to USTR.gov)

June 14, 2012While Battle against ACTA Rages, next Clash against TPP Looms (links to CitizenVox)

June 13, 2012Controversial Trade Pact Text Leaked – Investment Chapter of TPPA

June 8, 2012Reuters: China Changes Patent Law in Fight for Cheaper Drugs (links to Reuters)

June 8, 2012The New York Times: Obama Was Pushed by Drug Industry, E-mails Suggest (links the the NYTimes)

June 1, 2012Huffington Post: U.S. Trade Position Protecting High Drug Prices Blasted By U.N. Agencies (links to Huffington Post)

May 31, 2012UNAIDS/UNDP Press Release (links to Don’t trade our lives away) | UNAIDS/UNDP Brief (Links to Asia-Pacific UNDP)

May 30, 2012Public Citizen Global Access to Medicines Program Director Peter Maybarduk:TPP Chiefs Raise Doubts about USTR’s Corporate IP Wish List

May 25, 2012 Public Citizen Global Access to Medicines Program Director Peter Maybarduk: “Heavy-handed” TPP Tactics from US Trade Rep

May 23, 2012Huffington Post: Key Senate Democrat Joins Bipartisan Trade Revolt Against Obama (links to Huffington Post)

May 22, 2012IP Watch: Nobel Laureate, Other Experts Hail WHO Effort on Medcines R&D Framework (links to ip-watch.org)

May 22, 2012Techdirt: Some Countries Want To Fix TPP…By Making It More Like ACTA (links to techdirt.com)

May 22, 2012Public Citizen Health Research Group: Pharmaceutical Companies Must Be Held Fully Accountable for Defrauding the Government

May 18, 2012Pharmalot: Malaysians Seek License For Abbott AIDS Drug (links to Pharmalot)

May 17, 2012USTR Announces Next TPP Round in San Diego July 2-10 (links to Infojustice.org)

May 17, 2012Ars Technica: Exporting copyright: Inside the secretive Trans-Pacific Partnership (links to arstechnica.com)

May 16, 2012Melinda St. Louis of Public Citizen’s Global Trade Watch talking jobs, medicines & TPP on RT News (links to youtube.com) & Maira Sutton of Electronic Frontier Foundation talking copyright, the internet & TPP on RT News (links to youtube.com)

May 16, 2012USTR Gone Rogue (links to publicknowledge.org)

May 16, 2012Huffington Post: Darrell Issa Questions Obama On Trans-Pacific Partnership, Leaks Key Text Of Trade Deal (links to huffingtonpost.com)

May 16, 2012Focus Daily News: Texas rally and march for transparency in trade negotiations (links to focusdailynews.com)

May 16, 2012Ars Technica: ACTA deathwatch: profs call process unconstitutional, Europe revolts (links to arstechnica.com)

May 16, 2012 Melinda St. Louis of Public Citizen’s Global Trade Watch talking jobs, medicines & TPP on RT News (links to youtube.com) & Maira Sutton of Electronic Frontier Foundation talking copyright, the Internet & TPP on RT News (links to youtube.com)

May 16, 2012 USTR Gone Rogue (links to publicknowledge.org)

May 16, 2012Huffington Post: Darrell Issa Questions Obama On Trans-Pacific Partnership, Leaks Key Text Of Trade Deal (links to huffingtonpost.com)

May 16, 2012News: Texas rally and march for transparency in trade negotiations (links to focusdailynews.com)

May 16, 2012Ars Technica: ACTA deathwatch: profs call process unconstitutional, Europe revolts (links to arstechnica.com)

May 16, 2012Focus Daily News: Texas rally and march for transparency in trade negotiations (links to focusdailynews.com)

May 15, 2012US Rep. Waxman says on TPP, the Obama administration “needs to go back to the drawing board …not pose unnecessary barriers to poor patients seeking access to low cost generic medicines” (links to infojustice.org)

May 15, 2012US Rep. Issa calls for public input on the Feb. 2011 leaked US TPP intellectual property (IP) proposal; calls for transparency in international IP agreements (links to issa.house.gov)

May 14, 2012TPP: Internet Freedom Activists Protest Secret Trade Agreement Being Negotiated This Week (links to eff.org)

May 14, 2012ACTA-As-Counterproposal at TPP Negotiations; News from Dallas Round (links to infojustice.org)

May 14, 2012Free Speech Radio News: Watchdogs push for more transparency in Pacific free trade deal (links to fsrn.org)

May 13, 2012Reuters: Secrecy Needed in trade talks: Ron Kirk (links to reuters.com)

May 13, 2012The Raw Story: US Trade Rep. given ‘Corporate Power Tool’ award for secret treaty talks (links to rawstory.com)

May 12, 2012Yes Lab: Party ends badly for U.S. trade reps, federal agents (links to yeslab.org)

May 12, 2012Citizens Trade Campaign: Texans demand a public voice in secretive Trans-Pacific trade negotiations (links to citizenstrade.org)

May 10, 2012Listen to Public Citizen’s Global Access to Medicines Program Director Peter Maybarduk discussing the Trans-Pacific Partnership Agreement (TPP) on Free Speech Radio News (links to fsrn.org)

May 10, 2012Kirk Responds to TPP Transparency Demands (links to infojustice.org)

May 10, 2012Chile Threatens to Pull out of TPP because of US IP demands (links to infojustice.org)

May 9, 2012Law Professors Call for Trans-Pacific Partnership (TPP) Transparency (links to infojustice.org)

May 8, 2012Sen. Al Franken Urges Transparency on the Trans-Pacific Partnership (links to Minnesota Fair Trade Coalition)

May 8, 2012Citizen Trade Campaign: Coalition demands transparency in Trans-Pacific trade negotiations (link to citizenstrade.org)

May 7, 2012The Dallas Morning News: Trade talks begin in Addison between U.S., eight other nations (link to dallasnews.com)

May 7, 2012Inter Press Service: Next Round of Pacific Trade Talks Pact to Be Lengthy, Secretive (ipsnews.net)

May 4, 2012Huffington Post: Why Is the TPP Such a Big Secret? (link to huffingtonpost.com)

May 3, 2012Huffington Post: Congress Revolts on Obama Plan That Would Ban “Buy American” (link to huffingtonpost.com)

April 21, 2012IP Watch: Kenyan High Court’s Overturning of Anti-Counterfeit Law Hailed (links to ip-watch.org)

April 20, 2012I Love Chile: Chilean Officials Question Benefits of Trans-Pacific Partnership (links to ilovechile.cl)

April 18, 2012Diario Financiero: Senador Ricardo Lagos Weber – Acuerdo Transpacífico contenidos y legitimidad

April 13, 2012Techdirt: Once Again, Public Interest Groups Kicked Out When Trying To Present Concerns About TPP (link to www.techdirt.com)

April 12, 2012Briefing Memo: Chile and the Trans-Pacific Partnership Agreement – Access to Medicines Risks & Continued Bullying from USTR

April 12, 2012Huffington Post: “Next SOPA” Going Global? (links to huffingtonpost.com)

April 10, 2012Public Citizen: U.S. Abandons Final Pretense of Transparency or Inclusion of Consumer, Health, Environmental, Labor Perspective in Trans-Pacific Partnership (TPP) Talks (link to citizen.org)

April 5, 2012US Decreases Stakeholder Process for TPP (links to infojustice.org)

April 4, 2012US Abbandons TPPA ‘fig-leaf of transparency’ (links to voxy.co.nz)

March 20, 2012Wyden files legislative amendments to require transparency in TPPA and Congressional approval for ACTA (links to keionline.org)

March 20, 2012The Conversation: Australia should defend neighbors in Trans-Pacific Partnership negotiations (links to theconversation.edu.au)

March 19, 2012Expanding Access to Treatment for Hepatitis C in Resource-LImited Settings: Lessons from HIV/AIDS (Clinical Infectious Diseases Advance Access)

March 19, 2012Pharma in Focus: Alphapharm raises trade pact fear (link to pharmainfocus.com)

March 15, 2012Unanimously passed Maine House Resolution calling for transparency in the Trans-Pacific Partnership Agreement (TPPA) (links to mainelegislature.org)

March 14, 2011GTPI supports judicial decision annulling patent HIV/AIDS medicine (link to www.patentes.org.br)

March 13, 2012Lori Wallach of Public Citizen’s Global Trade Watch on the TPP: A Stealth Attack on Democratic Governance (links to prospect.org)

March 12, 2012Knowledge Ecology International (KEI) Notes From the Eleventh Round of TPPA negotiations in Melbourne, Australia (links to keionline.org)

March 12, 2012Comments from James Love of Knowledge Ecology International (KEI) on the granting of compulsory license on patents for the cancer drug sorafenib tosylate by India and news articles on the license (links to keionline.org)

March 12, 2012 First ever compulsory license granted in India for the cancer drug sorafenib tosylate

March 9, 2012Folha.com: Decisão da Justiça anula patente de droga anti-Aids (link to www1.folha.uol.com.br) Brazilian court annuls patent on HIV/AIDS medicine (Kaletra) (in Portuguese)

March 9, 2012Inter Press Service News Agency: Trans-Pacific Trade Pact Reveals U.S.’s Unbridled Corporate Agenda

March 8, 2012Civil Society requests TPP Chilean negotiations information from President Pinera

March 7, 2012Senator Ron Wyden presses USTR Kirk on ACTA and TPP secrecy (links to youtube.com)

March 6, 2012Deborah Gleeson of La Trobe University on Australian radio discussing the Trans-Pacific Free Trade Agreement (TPP) and investor-state dispute settlement, tobacco control & access to medicines (links to thewire.org.au)

March 6, 2012Judit Rius of Médecins Sans Frontières/Doctors Without Borders on Australian radio discussing the Trans-Pacific Free Trade Agreement (TPP) and access to medicines (links to abc.net.au)

March 5, 2012Kelly Nichols of Médecins Sans Frontières/Doctors Without Borders op-ed in Canberra Times on the Trans-Pacific Free Trade Agreement (TPP) and access to medicines (links to canberratimes.com.au)

March 1, 2012Rob Lake of the Australian Federation of AIDS Organisations on Australian radio discussing TPP and access to medicines

February 29, 2012Over 100 Vietnamese health advocacy groups release declaration on the Trans-Pacific FTA and access to medicines

February 21, 2012 – IP-Watch, Special Report: “TPP negotiations to heat up in Melbourne over patents, copyright, medicines” (link to twnside.org.sg)

February 10, 2012NHK World: Malaysia: Opposing the TPP (links to www3.nhk.or.jp)

February 10, 2012Amnesty International: ACTA a “Pandora’s Box” of Potential Human Rights Violations; EU Governments Should Not Join

February 9, 2012Health Groups’ Letter to U.S. Secretary of Commerce Against Corporate Sponsorship of Africa IP Forum (KEI, MSF, Health GAP, Oxfam, The George Washington University & Public Citizen)

February 5, 2012New York Times on ACTA threat to internet and access to medicines (links to nytimes.com)

February 2, 2012-Big Money’s Next Trade Goal Is ‘NAFTA With Asia’ (links to huffingtonpost.com)

January 31, 2012Public Citizen Applauds EU Commission Call for Removal of Linkage Between Patents and Generic Medicines Authorization

January 31, 2012Webcast of Public Forum on IP and the Trans-Pacific FTA – Panels discuss copyright provisions & provisions affecting access to medicines – Fast -forward to 1:33:15 for PC Access to Medicines Program Director Peter Maybarduk (links to infojustice.org)

January 30, 2012Obama’s Free Trade Agreement: Backdoor Deal with Corporate America? (link to laprogressive.com)

January 26, 2012KEI asks Senator Leahy (D-VT) to demand greater transparency in the Trans-Pacific free trade agreement (links to keionline.org)

January 13, 2012KEI Comment for House Committee on Ways & Means Hearing on Trans-Pacific Free Trade Agreement and KEI Reponse to Federal Register notice seeking comments regarding Canada’s interest in Trans-Pacific FTA negotiations (both link to keionline.org)

January 5, 2012Public Citizen Global Access to Medicines Program Director Peter Maybarduk’s Presentation on Access to Medicines & IP Enforcement at American University Washington College of Law (June 2010)

January 5, 2012Public Citizen Global Access to Medicines Program Director Peter Maybarduk’s Presentation on ACTA at American University Washington College of Law (June 2010)

December 22, 2011A brief history of Johnson & Johnson’s refusal to negotiate with the Medicines Patent Pool

December 21, 2011Abbott Laboratories responds with letter to the Vietnam Network of People Living with HIV

December 20, 2011Working Group on International Property (GTPI) on Brazilian Patent Office’s decision to prioritize examination of the patent application related to heat-stable ritonavir and lopinavir/ritonavir (links to deolhonaspatentes.org.br)

December 19, 2011Charts comparing pharmaceutical patent and data provisions in leaked U.S. proposals to the TPFTA, TRIPS Agreement and FTAs in negotiating countries (now with long and short form versions

December 16, 2011PC’s Op-ed in the Advocate: U.S. AIDS Policy vs. U.S. Trade Policy

December 15, 2011Johnson & Johnson response to Public Citizen letter on the Medicines Patent Pool

December 13, 2011KPFA Radio Interview with Global Access to Medicines Program Director, Peter Maybarduk; Matt Kavanagh, HealthGAP; & Ellen Shaffer, CPATH (recorded December 2, 2011)

December 10, 2011Public Citizen Brief on the Medicines Patent Pool

December 9, 2011Dr. Burcu Kilic’s presentation on innovation and intellectual property systems at the Malaysian round

December 7, 2011Today, Public Citizen sent a letter to Tibotec/Johnson & Johnson urging them to negotiate licensing with the Medicines Patent Pool

December 5, 2011Chart comparing pharmaceutical patent and data provisions in leaked U.S. proposals to the TPFTA, TRIPS Agreement and FTAs in negotiating countries

December 1, 2011AIDS Treatment Revolution: Expand Generic Competition (links to truthout.org)

December 1, 2011Public Citizen World AIDS Day Statement: Expanding Global AIDS Treatment Through Generic Competition

November 22, 2011-Oxfam Paper on the Trans-Pacific FTA Leaked U.S. IP Chapter Proposal

November 21, 2011Clinton’s Global AIDS Fight May Be Hurt by U.S. Trade Initiative (links to bloomberg.com)

November 18, 2011Celebrating the 10th Anniversary of the Doha Declaration

November 16, 2011Global Action To Open Generic Competition For Key AIDS Drug (links to ip-watch.org)

November 15, 2011Public Citizen Global Access to Medicines Program Responds to PhRMA’s Claims on the Trans-Pacific Free Trade Agreement in The Hill (links to thehill.com)

November 11, 2011Sign on to Health GAP’s letter to President Obama asking him to scale up ARV treatment

November 10, 2011MSF: Brazilians demand greater access to crucial HIV drug (links to msfaccess.org)

November 10, 2011The Guardian: Unprecedented global campaign launches against pharma company (links to guardian.co.uk)

November 10, 2011Pharmalot: Activists Challenge Abbott Over Its AIDS Drug (links to pharmalot.com)

November 9, 2011Public Health Groups Launch Global Campaign Against Abbott Labs’ Monopoly on Critical AIDS Medicine

November 1, 2011Bangkok Post Editorial: Obama Administration Rolling Back Bush-era Stance on Access to Medicines; Opposition Abroad and Among NGOs is Near-Unanimous

October 25, 2011Spanish Translation of Public Citizen Global Access to Medicines Program’s Summary of the Impact of the U.S. Proposal to the Trans-Pacific Partnership on Access to Medicines in Peru and Spanish Translation of Public Citizen’s Comparative Analysis of the US Trans-Pacific FTA Proposal and Peruvian Law

October 24, 2011Stakeholder Forum Presentation Paper of Sharon Treat at the Lima Round of Trans-Pacific FTA Negotiations

October 24, 2011Stakeholder Forum Presentation of Edward Low (Positive Malaysian Treatment Access and Advocacy Group) at the Lima Round of Trans-Pacific FTA Negotiations

October 22, 2011Professor Sean Flynn’s reaction to the leaked Trans-Pacific FTA Chapter on Transparency (links to infojustice.org) and Professor Jane Kelsey’s Preliminary Analysis of the Draft Chapter on Domestic Coherence (links to citizenstrade.org)

October 22, 2011Public Citizen Global Access to Medicines Program’s Summary of the Impact of the U.S. Proposal to the Trans-Pacific Partnership on Access to Medicines in Peru

October 22, 2011Public Citizen’s Comparative Analysis of the US Trans-Pacific FTA Proposal and Peruvian Law

October 22, 2011Leaked Trans-Pacific FTA Texts Reveal U.S. Undermining Access to Medicines (links to citizenstrade.org)

October 19, 2011Congressional Letter to USTR on Preserving Access to Medicines in the Trans-Pacific FTA

October 14, 2011Vietnam and the Trans-Pacific FTA (Vietnamese Translation)

October 14, 2011Civil Society letter to Peruvian Minister of Trade: IP and Access to Medicines

October 13, 2011US Sen. Bernie Sanders speech on FTAs’ Negative Impact on Access to Medicines

October 12, 2011Oxfam America Analysis of USTR TEAM White Paper

October 11, 2011Excerpts of “New Trade Deal Would Benefit Big Pharma at AIDS Programs’ Expense (Vietnamese Translation)

October 7, 2011International Coalition of Treatment Activists: Letter to President Ollanta Humala Tasso regarding impact of TPP on the health of people with HIV in Peru

October 5, 2011New Trade Deal Would Benefit Big Pharma At AIDS Programs’ Expense (link to huffingtonpost.com)

October 4, 2011Prosa letter to President Ollanta Humala Tasso: requesting the President to take a position against TPP and US patent protection periods

September 30, 2011Summary of Peruvian News Stories on IP, the Trans-Pacific FTA, and Dangers to Access to Medicines

September 9, 2011Comparative Analysis of the U.S. Intellectual Property Proposal and Malaysian Law

September 5, 2011Malaysian Declaration on the Trans-Pacific FTA and Access to Medicines

September 2, 2011Comparative Analysis of the U.S. Intellectual Property Proposal and Australian Law

September 2, 2011“Patent Talks Lift Fear of Drug Price Rise” (links to canberratimes.com.au)

September 1, 2011“New Trade Agreement Threatens Australia’s Laws on Medicines and Tobacco” (links to blogs.crikey.com.au/croakey/)

August 30, 2011“ACTA, TPPA Opponents Cite Broken Promises On Medicines, One-Sided Copyright Provisions” (links to bna.com)

August 29, 2011Sign on Now to this Statement of Solidarity with Beaten Korean AIDS Activists

August 2, 2011Members of Congress Stand up for Access to Medicines in the Trans-Pacific FTA

July 27, 2011Public Citizen Quoted in New York Times Article, “A Trade Barrier to Defeating AIDS”

July 8, 2011Analysis of Leaked U.S. Paper on Eliminating Patent Pre-Grant Opposition

July, 2011 Leaked U.S. TPPA Paper on Eliminating Pre-grant Opposition

June 16, 2011Comparative Analysis of the U.S. Intellectual Property Proposal and Vietnamese Law

June 16, 2011Vietnam and the Trans-Pacific Partnership Agreement

May 10, 2011Leaked Cables Show U.S. Tried, Failed to Organize Against Ecuador Compulsory Licensing

February 23, 2011Trans-Pacific FTA Agreement: Leaked Intellectual Property Proposals – New Zealand: Proposed IP Chapter Text

February 23, 2011Trans-Pacific FTA Agreement: Leaked Intellectual Property Proposals – Chile: Preliminary Considerations for TPP IP Chapter

February 17, 2011Trans-Pacific FTA: Leaked Intellectual Property Proposals: United States: Jane Kelsey, “New Leaks of TPPA Text Show U.S. is Playing Hardball”

February 17, 2011U.S. TPP Partial IPR Text Goes Beyond Old FTA Provisions On Copyrights

February 15, 2011Letter from Trans-Pacific FTA Member Countries Health Groups to Trade Ministers on Safeguarding Access to Medicines in the Trans-Pacific Partnership Agreement (En Espanol),

February 14, 2011Civil Society letter to Chilean Minister of Foreign Relations: Requesting public access to TPP text and collaboration with civil society

February 10, 2011Leaked US Proposed IP Text to the Trans-Pacific FTA (links to keionline.org)

December 4, 2010Why the Trans Pacific Partnership Should Not Include Pharmaceutical Pricing Provisions, Program on Information Justice and Intellectual Property (PIJIP) at American University Washington College of Law

December 4, 2010Memo on Trans-Pacific FTA Negotiations and Access to Medicines

December 4, 2010Press Release: Leaked New Zealand Paper Challenges U.S. FTA Models in Trans-Pacific Trade Negotiations; Access to Medicines at Stake

December 3, 2010Analysis of the Leaked New Zealand Paper on IP and TPP, Public Citizen and Third World Network

December 3, 2010Leaked New Zealand Paper on Intellectual Property and the Proposed Trans-Pacific FTA

November 19, 2010Comments on USPTO Proposal for Incentivizing Humanitarian Licensing of Patented Technologies, joint submission with Medicins Sans Frontieres, Oxfam America and Knowledge Ecology International

September 2010One Year of the Peru-U.S. FTA: Study results in Spanish, Peruvian Network for Globalization with Equity (RedGE)

September 2010ACTA and Public Health;(links to digitalcommons.wcl.american.edu)

September 30, 2010Public Citizen letter to Indian Department of Industrial Policy and Promotion (DIPP) on compulsory licensing

September 10, 2010ACTA’s Scope and Access to Medicines

September 9, 2010Coalition Letter on the Proposed Trans Pacific FTA and Global Access to Medicines

May 25, 2010Comments to the European Commission on Customs Regulation 1383/2003

May 5, 2010Public Citizen letter to Dr. Margaret Chan, Director General of WHO on NGO access at the 2010 World Health Assembly

April 22, 2010Press Release: By Authorizing Generic Competition, Ecuador Cuts Cost of Key HIV/AIDS Drug

August, 2009 Ecuadorian Institute for Intellectual Property: Administrative Guide for the issuance of compulsory licenses for pharmaceutical products in Ecuador

July 2, 2009Essential Action letter to Consultations and Liaison Division (BSL) of Foreign Affairs and International Trade Canada on ACTA

June 30, 2009Inter-American Dialogues: Will Venezuela Move to Modify Pharmaceutical Patents?

November 25, 2008 – Civil Society Letter to Dr. Gutierrez: Proposal to increase access to HIV treatment in Ecuador

March 21, 2008Essential Action Letter to USTR Director for IP: Comments on the Proposal of an Anti-Counterfeiting Trade Agreement

July 20, 2007Public Citizen: Envisioning a public interest response to counterfeiting and drug quality

Back to Access to Medicines Home Page